Yan‐Qiu Shi

756 total citations
22 papers, 588 citations indexed

About

Yan‐Qiu Shi is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yan‐Qiu Shi has authored 22 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Yan‐Qiu Shi's work include Drug Transport and Resistance Mechanisms (4 papers), Phytochemical compounds biological activities (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Yan‐Qiu Shi is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Phytochemical compounds biological activities (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Yan‐Qiu Shi collaborates with scholars based in China, United Kingdom and Japan. Yan‐Qiu Shi's co-authors include Hong‐Xiang Lou, Song Li, Xian‐Jun Qu, Huiqing Yuan, Zhaoping Liu, Yongxiang Liao, Changjun Zhu, Yanna Cheng, Chunfeng Xie and Jian‐Bo Qu and has published in prestigious journals such as European Journal of Pharmacology, Cancer Letters and Nanotechnology.

In The Last Decade

Yan‐Qiu Shi

22 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan‐Qiu Shi China 14 243 127 126 105 65 22 588
Lailiang Qu China 16 281 1.2× 75 0.6× 73 0.6× 67 0.6× 66 1.0× 26 507
N. Boyer France 16 383 1.6× 19 0.1× 222 1.8× 41 0.4× 84 1.3× 25 792
Chihiro Ito Japan 15 238 1.0× 15 0.1× 185 1.5× 71 0.7× 105 1.6× 46 661
Christopher R. Coxon United Kingdom 15 499 2.1× 26 0.2× 234 1.9× 55 0.5× 18 0.3× 34 846
Chunhui Liu China 14 190 0.8× 16 0.1× 254 2.0× 27 0.3× 135 2.1× 24 696
Siyang Song China 12 169 0.7× 19 0.1× 91 0.7× 19 0.2× 92 1.4× 18 365
Hao‐Yu Tang China 16 268 1.1× 22 0.2× 179 1.4× 50 0.5× 260 4.0× 27 691
Dietmar Hoffmann United States 11 581 2.4× 50 0.4× 86 0.7× 57 0.5× 511 7.9× 17 985

Countries citing papers authored by Yan‐Qiu Shi

Since Specialization
Citations

This map shows the geographic impact of Yan‐Qiu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Qiu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Qiu Shi more than expected).

Fields of papers citing papers by Yan‐Qiu Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Qiu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Qiu Shi. The network helps show where Yan‐Qiu Shi may publish in the future.

Co-authorship network of co-authors of Yan‐Qiu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Qiu Shi. A scholar is included among the top collaborators of Yan‐Qiu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Qiu Shi. Yan‐Qiu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yan‐Qiu & Ping Qian. (2019). Simulation Research of Magnetic Modulation Sensor Based on Permalloy. 1 indexed citations
2.
Hong, Ee Rea, et al.. (2017). A meta-analysis of single-case research on the use of tablet-mediated interventions for persons with ASD. Research in Developmental Disabilities. 70. 198–214. 40 indexed citations
3.
Xu, Wenwen, Junjie Gu, Qingling Ren, et al.. (2015). NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway. Tumor Biology. 37(4). 4493–4500. 38 indexed citations
4.
Zhu, Shanshan, Yusheng Zhang, X. D. Sheng, et al.. (2014). Deacetyl-mycoepoxydiene, isolated from plant endophytic fungi Phomosis sp. demonstrates anti-microtubule activity in MCF-7 cells. Biomedicine & Pharmacotherapy. 69. 82–89. 6 indexed citations
5.
Yue, Bin, Cuirong Zhao, Huimin Xu, et al.. (2012). Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(1). 2194–2203. 10 indexed citations
6.
Shi, Yan‐Qiu, Xiulan Xin, Qipeng Yuan, et al.. (2012). Microbial biotransformation of kurarinone byCunninghamella echinulataAS 3.3400. Journal of Asian Natural Products Research. 14(11). 1002–1007. 13 indexed citations
7.
Shi, Yan‐Qiu, Xiulan Xin, & Qipeng Yuan. (2011). Improved lycopene production by Blakeslea trispora with isopentenyl compounds and metabolic precursors. Biotechnology Letters. 34(5). 849–852. 21 indexed citations
8.
Ji, Mei, Yan‐Qiu Shi, & Hong‐Xiang Lou. (2011). Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts. BioScience Trends. 5(5). 192–197. 9 indexed citations
9.
Shen, Jie, Gang Li, Qinglin Liu, et al.. (2010). Marchantin C: A potential anti-invasion agent in glioma cells. Cancer Biology & Therapy. 9(1). 33–39. 27 indexed citations
10.
Wang, Yancai, Dianrui Zhang, Zhaoping Liu, et al.. (2010). In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery. Nanotechnology. 21(15). 155104–155104. 87 indexed citations
11.
Gao, Jie, Chengqin Wang, X. D. Sheng, et al.. (2010). Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumor Biology. 32(1). 53–61. 39 indexed citations
12.
Sun, Lirui, Julia Li Zhong, Shu‐Xiang Cui, et al.. (2010). Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells. Pharmacological Reports. 62(2). 333–342. 5 indexed citations
13.
Liu, Zhaohua, Zhaoping Liu, Yan‐Qiu Shi, & Gengyin Zhou. (2010). Evaluation of the immunosensitizing potential of chlorogenic acid using a popliteal lymph node assay in BALB/c mice. Food and Chemical Toxicology. 48(4). 1059–1065. 9 indexed citations
14.
Shi, Yan‐Qiu, et al.. (2010). Effect of Chlorogenic acid on mast cell-dependent anaphylactic reaction. International Immunopharmacology. 10(9). 1135–1141. 31 indexed citations
15.
16.
Shi, Yan‐Qiu, Xian‐Jun Qu, Yongxiang Liao, et al.. (2008). Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. European Journal of Pharmacology. 584(1). 66–71. 49 indexed citations
17.
Shi, Yan‐Qiu, Yongxiang Liao, Xian‐Jun Qu, et al.. (2008). Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells. Cancer Letters. 262(2). 173–182. 48 indexed citations
18.
Shi, Yan‐Qiu, Changjun Zhu, Huiqing Yuan, et al.. (2008). Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Letters. 276(2). 160–170. 53 indexed citations
19.
Qu, Jian‐Bo, Chunfeng Xie, Mei Ji, Yan‐Qiu Shi, & Hong‐Xiang Lou. (2007). Water‐Soluble Constituents from the Liverwort Marchantia polymorpha. Helvetica Chimica Acta. 90(11). 2109–2115. 19 indexed citations
20.
Chen, Chang, Yan‐Qiu Shi, Jing Song, et al.. (2006). Delivery of Nitric Oxide Released from .BETA.-Gal-NONOate Activation by .BETA.-Galactosidase and Its Activity against Escherichia coli. Biological and Pharmaceutical Bulletin. 29(6). 1239–1241. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026